BCDA BioCardia, Inc.
Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 925741 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY-100.0%
TTM net income YoY-3.5%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-950.1%
ROA-230.6%
ROIC (approx.)—
Asset turnover0.00x
Leverage & solvency
Liabilities / assets73.8%
Debt / equity0.00x
Current ratio1.12x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.90x
Accruals ratio-22.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $0 | $58,000 |
| R&D expense | $4.96M | $4.39M |
| SG&A expense | $3.32M | $3.67M |
| Operating income | -$8.28M | -$8.00M |
| Income tax | $0 | $0 |
| Net income | -$8.23M | -$7.95M |
| EBITDA | -$8.25M | -$7.93M |
| EPS (basic) | -1.23 | -2.90 |
| EPS (diluted) | — | — |
| Balance sheet | ||
| Cash & equivalents | $2.50M | $2.37M |
| Receivables | $20,000 | $0 |
| Current assets | $2.73M | $2.62M |
| PP&E, net | $16,000 | $33,000 |
| Total assets | $3.41M | $3.72M |
| Current liabilities | $2.43M | $2.32M |
| Total liabilities | $2.52M | $2.89M |
| Shareholders' equity | $895,000 | $837,000 |
| Shares outstanding | 10.76M | 4.60M |
| Cash flow statement | ||
| Operating cash flow | -$7.44M | -$7.89M |
| Capital expenditure | $7,000 | $6,000 |
| Free cash flow | -$7.44M | -$7.89M |
| Investing cash flow | -$7,000 | -$6,000 |
| Financing cash flow | $7.57M | $9.16M |
| Depreciation & amortization | $24,000 | $67,000 |
| Stock-based compensation | $430,000 | $741,000 |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· This company does not report gross profit in XBRL.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.